iamYiam Ltd (syd Life AI) is a global B2B SaaS headquartered in London, UK. Developed during 5 years of R&D, syd™ is a Life Quality & Preventive Health technology powered by proprietary AI, >1 million scientific research papers and real world evidence, delivering predictive, actionable data solutions that empower human-centric industries to revolutionise Life Quality at scale.
Already active in 26 countries, syd has a proven impact, supporting hundreds of thousands of users and targeting the ambitious goal of improving the Life Quality & health of millions of people. The platform’s metrics are impressive: a 48% reduction in stress, anxiety, and depression among users, a 23% boost in productivity, a 15% increase in retention, and a 10-25x ROI for organizations. A 3-month randomized control trial with UK’s NHS staff demonstrated a 16% reduction in anxiety, a 12% decrease in depression, and a 14% drop in stress levels. syd's impact and innovation have earned it the EU Seal of Excellence and recognition as the Gold Standard for measuring Life Quality and the Future of Health by WIPO & Cornell University.
